Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 93957-50-7 | Product Number: F0819
(E)-3-[3-(4-Fluorophenyl)-1-isopropylindol-2-yl]acrolein
Purity: >98.0%(GC)
Synonyms:
- (E)-3-[3-(4-Fluorophenyl)-1-isopropylindol-2-yl]propenal
Product Documents:
Size | Unit Price | Belgium | Japan* | Quantity |
---|---|---|---|---|
5G |
€76.00
|
1 | 1 |
|
25G |
€266.00
|
2 | 5 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Product Number | F0819 |
Purity / Analysis Method | >98.0%(GC) |
Molecular Formula / Molecular Weight | C__2__0H__1__8FNO = 307.37 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive |
CAS RN | 93957-50-7 |
Reaxys Registry Number | 5443009 |
PubChem Substance ID | 160871011 |
MDL Number | MFCD03840863 |
Specifications
Appearance | Light orange to Yellow to Green powder to crystal |
Purity(GC) | min. 98.0 % |
Melting point | 129.0 to 133.0 °C |
NMR | confirm to structure |
Properties (reference)
Melting Point | 131 °C |
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H317 : May cause an allergic skin reaction. H410 : Very toxic to aquatic life with long lasting effects. |
Precautionary Statements | P261 : Avoid breathing dust. P273 : Avoid release to the environment. P280 : Wear protective gloves. P391 : Collect spillage. P362 + P364 : Take off contaminated clothing and wash it before reuse. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. |
Related Laws:
Transport Information:
UN Number | UN3077 |
Class | 9 |
Packing Group | III |
HS Number | 2933998090 |
Application
A Synthetic Intermediate of Fluvastatin
This product has been used as a synthetic intermediate of fluvastatin [F0820, sodium salt], a HMG-CoA reductase inhibitor.
References
- Asymmetric synthesis of 3,5-dihydroxy-6(E)-heptenoate-containing HMG-CoA reductase inhibitors
- An Improved Manufacturing Process for Fluvastatin
- Facile and Highly Enantioselective Synthesis of (+)- and (-)- Fluvastatin Fluvastatin and Their Analogues
Application
Synthesis of HMG-CoA Reductase Inhibitors
References
- Asymmetric synthesis of 3,5-dihydroxy-6(E)-heptenoate-containing HMG-CoA reductase inhibitors
- An Improved Manufacturing Process for Fluvastatin
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.